Literature DB >> 8096239

Mercury-induced autoreactive anti-class II T cell line protects from experimental autoimmune encephalomyelitis by the bias of CD8+ antiergotypic cells in Lewis rats.

M Castedo1, L Pelletier, J Rossert, R Pasquier, H Villarroya, P Druet.   

Abstract

Brown-Norway (BN) rats injected with HgCl2 develop a systemic autoimmune disease associated with a polyclonal B cell activation, due to autoreactive T cells specific for self-class II molecules, while Lewis (LEW) rats injected with HgCl2 do not exhibit autoimmunity and develop a non-antigen-specific, CD8-mediated immunosuppression assessed by a depression of T cell functions, and a protection against experimental autoimmune encephalomyelitis (EAE). Resistance to HgCl2-induced autoimmunity is not due to these suppressor cells since treatment with an anti-CD8 monoclonal antibody (mAb) did not allow autoimmunity to appear. The absence of autoimmunity in this strain could result from the absence of autoreactive T cells, or from quantitative or qualitative differences of these cells between susceptible and resistant strains. In the present study, we show that CD4+ anti-class II T cells are present in HgCl2-injected LEW rats and are as frequent as in BN rats when assessed by limiting dilution analysis. LEW CD4+ autoreactive T cell lines were derived. They proliferated in the presence of normal class II-bearing cells, secreted interleukin 2, and did not induce B cells to produce immunoglobulins. Transfer of one of these lines, LEW Hg A, into normal LEW rats led to the appearance of CD8+ cells responsible for a non-antigen-specific immunosuppression that induced complete protection from EAE. Immunosuppression was abrogated after treatment with an anti-CD8 mAb. In vitro, CD8+ cells from rats injected with the LEW Hg A T cell line proliferated in the presence of activated T cells whatever their origin. We conclude that HgCl2 induces CD4+ autoreactive T cells that proliferate in the presence of class II+ cells in susceptible BN as well as in resistant LEW rats. But while these cells collaborate with B cells to produce autoantibodies in BN rats, they initiate in LEW rats a suppressor circuit involving antiergotypic CD8+ suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096239      PMCID: PMC2190974          DOI: 10.1084/jem.177.4.881

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

Review 1.  Revisiting and revising suppressor T cells.

Authors:  B R Bloom; P Salgame; B Diamond
Journal:  Immunol Today       Date:  1992-04

2.  Mercuric chloride-induced anti-glomerular basement membrane antibodies in the rat: genetic control.

Authors:  E Druet; C Sapin; E Günther; N Feingold; P Druet
Journal:  Eur J Immunol       Date:  1977-06       Impact factor: 5.532

3.  Polyclonal IgE increase after HgCl2 injections in BN and LEW rats: a genetic analysis.

Authors:  C Sapin; F Hirsch; J P Delaporte; H Bazin; P Druet
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues.

Authors:  A N Barclay
Journal:  Immunology       Date:  1981-04       Impact factor: 7.397

6.  Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction.

Authors:  P L Romain; C Morimoto; J F Daley; L S Palley; E L Reinherz; S F Schlossman
Journal:  Clin Immunol Immunopathol       Date:  1984-01

7.  Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus.

Authors:  T Fukumoto; W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1982-03       Impact factor: 5.532

8.  Two subsets of rat T lymphocytes defined with monoclonal antibodies.

Authors:  R J Brideau; P B Carter; W R McMaster; D W Mason; A F Williams
Journal:  Eur J Immunol       Date:  1980-08       Impact factor: 5.532

9.  Polyclonal effect of HgCl2 in the rat, its possible role in an experimental autoimmune disease.

Authors:  F Hirsch; J Couderc; C Sapin; G Fournie; P Druet
Journal:  Eur J Immunol       Date:  1982-07       Impact factor: 5.532

10.  MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen.

Authors:  G P Spickett; M R Brandon; D W Mason; A F Williams; G R Woollett
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  6 in total

1.  Pretreatment of lymphocytes with mercury in vitro induces a response in T cells from genetically determined low-responders and a shift of the interleukin profile.

Authors:  H Hu; M Abedi-Valugerdi; G Möller
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 2.  T cell subsets in glomerular diseases.

Authors:  S Florquin; M Goldman
Journal:  Springer Semin Immunopathol       Date:  1994

Review 3.  Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans.

Authors:  L M Bagenstose; P Salgame; M Monestier
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  Differential regulation of expression of the MHC class II molecules RT1.B and RT1.D on rat B lymphocytes: effects of interleukin-4, interleukin-13 and interferon-gamma.

Authors:  A Roos; E J Schilder-Tol; M A Chand; N Claessen; F G Lakkis; D W Pascual; J J Weening; J Aten
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

5.  Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in brown Norway rats, directly triggers T cells to produce interleukin-4.

Authors:  P Prigent; A Saoudi; C Pannetier; P Graber; J Y Bonnefoy; P Druet; F Hirsch
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines.

Authors:  F Bridoux; A Badou; A Saoudi; I Bernard; E Druet; R Pasquier; P Druet; L Pelletier
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.